Tocilizumab-aazg for Hemorrhage: Reduction of Ischemic Vascular Events
Abroad (travel likely)RecruitingPHASE1
Conditions
Aneurysmal Subarachnoid Hemorrhage · Delayed Cerebral Ischemia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Florida Health (UF Health), Gainesville, Florida, United States
Contact: Principal Investigator (Brian Hoh, MD)
Study leads
Brian Hoh, MD
Principal Investigator
University of Florida